Pharmacologic and clinical evaluation of posaconazole

JN Moore, JR Healy, WK Kraft - Expert review of clinical …, 2015 - Taylor & Francis
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of
invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal …
被引用次数：74 相关文章
[HTML] nih.gov

[HTML][HTML] Pharmacologic and clinical evaluation of posaconazole

JN Moore, JR Healy, WK Kraft - Expert review of clinical …, 2015 - ncbi.nlm.nih.gov
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of
invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal …

Pharmacologic and clinical evaluation of posaconazole

JN Moore, JR Healy, WK Kraft - Expert review of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of
invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal …
[PDF] core.ac.uk

[PDF][PDF] Pharmacologic and clinical evaluation of posaconazole.

JN Moore, JR Healy, WK Kraft - core.ac.uk
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of
invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal …

Pharmacologic and clinical evaluation of posaconazole.

JN Moore, JR Healy, WK Kraft - 2016 - jdc.jefferson.edu
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of
invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal …

Pharmacologic and clinical evaluation of posaconazole.

JN Moore, JR Healy, WK Kraft - Expert Review of Clinical …, 2015 - europepmc.org
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of
invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal …

Pharmacologic and clinical evaluation of posaconazole.

JN Moore, JR Healy, WK Kraft - Expert Review of Clinical …, 2015 - europepmc.org
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of
invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal …